Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Launches New Grants Program to Support HIV Cure

[ Business Wire] – Gilead Sciences, Inc. today announced it will be providing grants for up to three years to academic institutions, nonprofit organizations and community groups engaged in HIV cure activities. Read more on this. Gilead Sciences Inc. (GILD) , with a current market cap of $126.52B, started trading this morning at $88.46. Shares have traded today between $88.05 and $89.18 per share with the price of the stock fluctuating between $81.89 to $123.37 over the last 52 weeks. Priced at 7.32x this year’s forecasted earnings, GILD shares are relatively expensive compared to the industry ’s -1.62x forward p/e ratio. The company pays shareholders $1.72 per share in dividend income per year, for a current yield of 1.97%. According to a consensus of 20 analysts, the earnings estimate of $3.07 per share would be $0.13 better than the year-ago quarter and a $0.15 sequential increase. In looking at the bigger picture, the full-year EPS estimate of $12.16 would be a $0.45 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $7.98 Billion. If realized, that would be a 5.14% increase over the year-ago quarter. More recently, Standpoint Research Initiated GILD at Buy (Feb 3, 2016). Previously, Credit Suisse Initiated GILD at to Outperform. When considering if the stock is under or overvalued, the average price target is $116.68, which is 31.90% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Technical Scrutiny on Biotechnology Stocks — Gilead Sciences, Sarepta Therapeutics, Dyax Corp., and Baxalta Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences Announces Fourth Quarter 2015 Dividend Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Release Third Quarter 2015 Financial Results on Tuesday, October 27, 2015